ClinicalTrials.gov
public full text
Public Domain
A Study of AL2846 on Tolerance and Pharmacokinetics
A study of AL2846,a C-met/Hepatocyte growth factor tyrosine kinase inhibitor,in patients with advanced cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Dose Dense MVAC for Muscle Invasive Bladder Cancer#1111623
- A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations#1045293
- Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication#1127256
- ZD6474(Vandetanib) + Alimta Combo Study#873152
- Study of Lenvatinib in Patients With Advanced Cancer and Aberrations in FGF/FGFR Signaling#879872
Record · ID 1382697
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive